Head‐to‐head comparison of the <scp>MyGen</scp> e human papillomavirus–sexually transmitted infection assay versus the Cobas 4800 human papillomavirus test for detecting high‐grade cervical intraepithelial neoplasia
Our study indicated that MHSA could be considered a valuable option for cervical cancer screening in China.
Authors
- Xingsheng Cai
- S Chen
- Yuan Yang (ORCID: https://orcid.org/0000-0002-6681-5451)
- Hang Zhou (ORCID: https://orcid.org/0000-0003-2719-790X)
- Yu Dai (ORCID: https://orcid.org/0000-0001-5456-095X)
- Tingyuan Li (ORCID: https://orcid.org/0009-0008-7915-0840)
- Ruoji Pi
- Hua Zhang
- Yiran Chen
- Wen Chen
- He Zhu
- Yuqian Zhao
Institutions
- King's College London (GB)
- Xiamen University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Shenzhen Maternity and Child Healthcare Hospital (CN)
- Kingmed Diagnostics (CN)
- Sichuan Cancer Hospital (CN)
Publication Details
- Journal
- International Journal of Gynecology & Obstetrics
- Published
- 2026-02-21
- DOI
- https://doi.org/10.1002/ijgo.70869
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00